At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
In Brief
An observational study for Pseudomonas Aeruginosa and Cystic Fibrosis. Completed, enrolled 53 participants across 1 site.
Detailed Summary
Pseudomonas aeruginosa (Pa) is the bacterium that causes one of the most consequential lung infections in people with CF. Many young children do not have Pa in their lungs but will become infected as they get older. The investigators want to learn more about how Pa is passed from person to person, especially to someone with Cystic Fibrosis (CF).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPseudomonas Aeruginosa, Cystic Fibrosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2012
First PostedJun 2012
Primary CompletionJun 2013
Study CompletionAug 2013
TodayJul 2026
First PostedJun 12, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJun 1, 2013
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.1 years ago